CymitQuimica logo

CAS 956014-19-0

:

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 8 produtos.
  • Thiourea, N'-[3,5-bis(trifluoromethyl)phenyl]-N-[4-bromo-2-(2H-tetrazol-5-yl)phenyl]-

    CAS:
    Fórmula:C16H9BrF6N6S
    Pureza:95%
    Cor e Forma:Solid
    Peso molecular:511.2423

    Ref: IN-DA003621

    250mg
    A consultar
    10mg
    143,00€
    25mg
    204,00€
    50mg
    343,00€
    100mg
    548,00€
  • NS 11021

    CAS:

    NS 11021

    Pureza:≥95%
    Peso molecular:511.24g/mol

    Ref: 54-BUP05521

    1mg
    A consultar
    5mg
    A consultar
    10mg
    A consultar
    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • 1-(3,5-Bis(Trifluoromethyl)Phenyl)-3-(4-Bromo-2-(2H-Tetrazol-5-Yl)Phenyl)Thiourea

    CAS:
    1-(3,5-Bis(Trifluoromethyl)Phenyl)-3-(4-Bromo-2-(2H-Tetrazol-5-Yl)Phenyl)Thiourea
    Fórmula:C16H9BrF6N6S
    Pureza:95%
    Peso molecular:511.24

    Ref: 54-PC108593

    10mg
    245,00€
    25mg
    343,00€
    50mg
    558,00€
    100mg
    830,00€
  • NS 11021

    CAS:
    NS 11021 (NS11021) , a novel opener of large-conductance Ca(2+)-activated K(+) channels
    Fórmula:C16H9BrF6N6S
    Pureza:97.26%
    Cor e Forma:Solid
    Peso molecular:511.24

    Ref: TM-T4294

    1mg
    42,00€
    5mg
    88,00€
    1mL*10mM (DMSO)
    89,00€
    10mg
    128,00€
    25mg
    263,00€
    50mg
    447,00€
    100mg
    760,00€
    200mg
    1.018,00€
  • NS 11021

    CAS:
    1-(3,5-Bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(2H-tetrazol-5-yl)phenyl)thiourea
    Fórmula:C16H9BrF6N6S
    Pureza:95%
    Peso molecular:511.24
  • NS 11021

    Produto Controlado
    CAS:
    Fórmula:C16H9BrF6N6S
    Cor e Forma:Neat
    Peso molecular:511.242

    Ref: TR-N926033

    100mg
    1.027,00€
  • NS 11021

    CAS:

    NS 11021 is a drug that inhibits the mitochondrial membrane potential, which is the driving force for ATP synthesis. It can be used to treat bowel disease and cardiac diseases such as hypertrophic cardiomyopathy. NS 11021 also has a pharmacological effect on channels that open in response to an increase in cytosolic calcium levels. This includes atrial and activated potassium channels, which are important for the propagation of action potentials in the heart. NS 11021 can also be used to treat experimental models of ischemia–reperfusion injury due to its ability to inhibit energy metabolism.

    Fórmula:C16H9BrF6N6S
    Pureza:Min. 95%
    Peso molecular:511.24 g/mol

    Ref: 3D-GNB01419

    25mg
    800,00€
    50mg
    1.207,00€
    100mg
    1.679,00€